7.3 C
New York
Wednesday, January 14, 2026

FDA’s new expert panels are rife with financial conflicts and fringe views

WASHINGTON (AP) — When the Food and Drug Administration needs outside guidance, it normally turns to a trusted source: a large roster of expert advisers who are carefully vetted for their independence, credentials and judgment. But increasingly, the agency isn’t calling them. Instead, FDA …

This post was originally published on this site

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

149,696FansLike
396,312FollowersFollow
2,640SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x